Natchura Pharma Limited
About Natchura Pharma Limited
Data last updated:
Natchura Pharma Limited is a public limited company based in Salem, Tamil Nadu, India. It operates in the alternative and holistic medicine segment of the healthcare sector. It was incorporated on 02 May 1995 and has been in existence for over 31 years.
The company is registered with the Registrar of Companies (ROC), Coimbatore, under CIN U24231TZ1995PLC028950.
The company has an authorised share capital of ₹1 Cr and a paid-up capital of ₹5 Lakh. It is led by directors including Govindarajulu Balapadmasri and Thirumagounder Selvam.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 10/1 Maravaneri Cross Street No.2, Salem, Tamil Nadu, India – 636007.
As per the financials filed for FY 2025, the company reported a revenue of ₹17.29 Lakh, a growth of 13% compared to the previous year. For the same year it recorded a net profit of ₹9.79 Lakh (net margin 56.6%) and EBITDA of ₹11.75 Lakh (EBITDA margin 68%). Revenue has grown at a compounded annual rate (CAGR) of 13% over three years and 21% over five years.
As per MCA filings, the company has open charges of ₹8 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN history
Natchura Pharma has one previous CIN (Corporate Identification Number): U24231TN1995PLC031203. The current CIN is U24231TZ1995PLC028950, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24231TZ1995PLC028950 | Current |
| U24231TN1995PLC031203 | Previous |
Contact details
Natchura Pharma Limited's registered office is in Salem, Tamil Nadu. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address10/1 Maravaneri Cross Street No.2, Salem, Tamil Nadu, India – 636007
- IndustryHealthcare, Alternative & Holistic Medicine
To see the full contact details of Natchura Pharma Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Natchura Pharma is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Natchura Pharma Limited, buy the company report.
Financials of Natchura Pharma Limited
FY 2025 filings availableNatchura Pharma Limited reported revenue of ₹17.29 Lakh (up 13% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 21% over five years, including 13% growth in the latest year. EBITDA rose 16% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹11.75 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹9.79 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 68% | ||||
| Net Profit Margin | 56.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Natchura Pharma Limited, buy the company report.
Board of directors of Natchura Pharma Limited
Natchura Pharma has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Govindarajulu Balapadmasri Also directs: Bepees Agro Products Private Limited, Mobanit Industries Private Limited, Pamba Pharma Private Limited and 5 more | Director | 02 May 1999 | 27 Years 6 Months | Current |
| Thirumagounder Selvam | Director | 30 Jun 2008 | 18 Years 4 Months | Current |
| Balaraman Mohankumar Also directs: Bepees Agro Products Private Limited, Mobanit Industries Private Limited, Pamba Pharma Private Limited and 5 more | Director | 02 May 1995 | 31 Years 6 Months | Current |
Peer comparison
Natchura Pharma Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| BK and BS Enterprises Private Limited | ₹17.34 Lakh (FY 2024) | -48.0% | Hyderabad, Telangana, India | |||
| Unicordis Pharma India Private Limited | ₹17.34 Lakh (FY 2016) | -2.0% | Salem, Tamil Nadu, India | |||
| Shashank Medi Pharma Private Limited | ₹17.33 Lakh (FY 2020) | -55.0% | Lucknow, Uttar Pradesh, India | |||
| Natchura Pharma Limitedthis company | ₹17.29 Lakh (FY 2025) | ₹9.79 Lakh | 56.6% | 13.0% | Salem, Tamil Nadu, India | |
| Sumanasham Pharma Private Limited | ₹17.27 Lakh (FY 2024) | 72.0% | Badangpet, Telangana, India | |||
| Biospace Medical System Private Limited | ₹17.25 Lakh (FY 2019) | -46.0% | Patna, Bihar, India |
To see the full peer comparison of Natchura Pharma Limited, buy the company report.
Auditor
Natchura Pharma Limited is audited by V.ANANTHAKRISHNAN for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| V.ANANTHAKRISHNAN | FY 2023 | 201134 |
Shareholding
The shareholding of Natchura Pharma Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Natchura Pharma Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 21 Jul 2023 | 100798382 | Indian Bank | ₹8 Cr | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Natchura Pharma Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Natchura Pharma Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Natchura Pharma Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Natchura Pharma Limited has 3 board changes on record since 1995: 3 appointments. The latest: Thirumagounder Selvam was appointed as Director on 30 Jun 2008.
Frequently asked questions
Natchura Pharma is an active public limited company based in Salem, Tamil Nadu, India. The company works in alternative and holistic medicine, within the healthcare industry. It was incorporated on 02 May 1995 (31+ years old) and is registered under CIN U24231TZ1995PLC028950.
Natchura Pharma has 3 current directors:
- Govindarajulu Balapadmasri - Director
- Thirumagounder Selvam - Director
- Balaraman Mohankumar - Director
The latest financial statements of Natchura Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The CIN (Corporate Identification Number) of Natchura Pharma is U24231TZ1995PLC028950. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Natchura Pharma was incorporated on 02 May 1995, making it 31+ years old. It is registered with the Registrar of Companies, Coimbatore.
The peers of Natchura Pharma by revenue are BK and BS Enterprises Private Limited, Unicordis Pharma India Private Limited, Shashank Medi Pharma Private Limited, Sumanasham Pharma Private Limited, Biospace Medical System Private Limited, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Thirumagounder Selvam was appointed as Director on 30 Jun 2008. Govindarajulu Balapadmasri was appointed as Director on 02 May 1999. Balaraman Mohankumar was appointed as Director on 02 May 1995.
The registered office of Natchura Pharma is at 101 Maravaneri Cross Street No.2, Salem, Tamil Nadu, India – 636007.
Natchura Pharma operates in the healthcare industry, in the alternative and holistic medicine segment.
Natchura Pharma has open charges of ₹8 Cr and no satisfied charges on record as per latest MCA filings.
The compliance status of Natchura Pharma is compliant as of 20 September 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
